What is considered short-term use of Keflex (Cephalexin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Short-Term Use of Cephalexin (Keflex)

Short-term use of cephalexin (Keflex) is typically considered to be a treatment duration of 5-14 days, depending on the specific infection being treated. This recommendation is based on established clinical practice guidelines for various infectious conditions.

Duration Guidelines by Infection Type

Skin and Soft Tissue Infections

  • Impetigo: 5-7 days 1
  • Cellulitis: 5-10 days
  • MSSA skin infections: 7-10 days 1

Urinary Tract Infections

  • Uncomplicated UTI in females: 5-7 days 2
  • Complicated UTI: 10-14 days

Respiratory Tract Infections

  • Pharyngitis/Tonsillitis: 10 days 3
  • Sinusitis: 5-7 days 4
  • Otitis media: 10 days 3

Dosing Considerations

The standard adult dosing for cephalexin varies by indication:

  • 250-500 mg four times daily for most infections 1
  • 500 mg twice daily has been shown to be as effective as four times daily dosing for uncomplicated UTIs 2

For children, the typical dosage is:

  • 25-50 mg/kg/day divided into 2-4 doses 1

Clinical Considerations

Benefits of Short-Term Use

  • Minimizes risk of adverse effects
  • Reduces likelihood of antibiotic resistance development
  • Improves patient adherence to therapy

Potential Adverse Effects

  • Gastrointestinal disturbances (most common)
  • Allergic reactions
  • Rare: C. difficile infection

Special Populations

Renal Impairment

  • Dosage adjustment required for patients with creatinine clearance <30 ml/min 5
  • In anephric patients, cephalexin can reach high, prolonged serum concentrations 6

Elderly

  • May require lower doses due to decreased renal function
  • Long-term prophylaxis has been studied using much lower doses (125-250 mg daily) 7

Important Considerations

  • Cephalexin is not recommended for long-term prophylaxis except in specific cases
  • First-generation cephalosporins like cephalexin are ineffective for Lyme disease 1
  • When transitioning from one antibiotic to cephalexin, the standard approach is to discontinue the first antibiotic when starting cephalexin 4

Conclusion

Short-term use of cephalexin refers to treatment courses lasting 5-14 days, with the specific duration determined by the type and severity of infection. The most recent evidence suggests that shorter courses (5-7 days) may be sufficient for many uncomplicated infections, while more severe or complicated infections may require longer treatment periods (10-14 days).

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Therapy Transition Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.